R. Gutzmer , P. Mohr , K. Kähler , P.A. Ascierto , M. Scalvenzi , K. Peris , G.M. Pérez-Pastor , R. Fernández-de-Misa , R. Botella Estrada , R. Hunger , S. Martelli , R. Arntz , A. Hauschild
{"title":"评估索尼替吉对局部晚期基底细胞癌患者长期安全性的多国授权后安全性研究(NISSO)中期分析:不良事件发生时间","authors":"R. Gutzmer , P. Mohr , K. Kähler , P.A. Ascierto , M. Scalvenzi , K. Peris , G.M. Pérez-Pastor , R. Fernández-de-Misa , R. Botella Estrada , R. Hunger , S. Martelli , R. Arntz , A. Hauschild","doi":"10.1016/j.ejcskn.2024.100044","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100396,"journal":{"name":"EJC Skin Cancer","volume":"2 ","pages":"Article 100044"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772611824000326/pdfft?md5=f28c545344ff2fc3a7040a4502876cb8&pid=1-s2.0-S2772611824000326-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: Time to onset of adverse events\",\"authors\":\"R. Gutzmer , P. Mohr , K. Kähler , P.A. Ascierto , M. Scalvenzi , K. Peris , G.M. Pérez-Pastor , R. Fernández-de-Misa , R. Botella Estrada , R. Hunger , S. Martelli , R. Arntz , A. Hauschild\",\"doi\":\"10.1016/j.ejcskn.2024.100044\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100396,\"journal\":{\"name\":\"EJC Skin Cancer\",\"volume\":\"2 \",\"pages\":\"Article 100044\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772611824000326/pdfft?md5=f28c545344ff2fc3a7040a4502876cb8&pid=1-s2.0-S2772611824000326-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJC Skin Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772611824000326\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJC Skin Cancer","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772611824000326","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: Time to onset of adverse events